Cocrystal Engineering in Pharmaceutical Formulations

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 29

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
Interests: crystal engineering; formulation development; controlled release

E-Mail Website
Guest Editor
Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA
Interests: pharmaceutical material science; physical pharmacy; crystal engineering; powder technology

Special Issue Information

Dear Colleagues,

The Pharmaceutics journal is pleased to announce this Special Issue, titled "Cocrystal Engineering in Pharmaceutical Formulations." Pharmaceutical cocrystals have emerged as a versatile platform for addressing long-standing challenges in small-molecule drug development, particularly the poor solubility, limited permeability, and suboptimal bioavailability that affect a majority of new chemical entities. Evolving from early serendipitous discoveries, cocrystal engineering has matured into a powerful approach that enhances drug performance while also preserving the intrinsic pharmacophore. Beyond solubility and dissolution improvements, cocrystals have demonstrated benefits in taste masking, stability enhancement, tabletability, and controlled release. These advances have already culminated in several commercial successes, including Entresto, Suglat, Steglatro, and Seglentis, underscoring regulatory recognition and therapeutic impact.

This Special Issue will focus on the design, synthesis, characterization, and application of pharmaceutical cocrystals. We welcome contributions on efficient cocrystal screening, drug–drug cocrystal design, mechanistic studies on structure–property relationships, and computational or data-driven approaches for cocrystal structure prediction. Research on scale-up strategies, regulatory and intellectual property aspects, as well as case studies bridging laboratory innovation to clinical and commercial translation, are of particular interest.

We invite researchers and pharmaceutical scientists to contribute original research and comprehensive reviews exploring the design, development, and application of cocrystals in pharmaceutical formulations for improved drug performance and therapeutic outcomes.

We look forward to receiving your contributions.

Dr. Chenguang Wang
Prof. Dr. Changquan Calvin Sun
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cocrystal engineering
  • pharmaceutical cocrystals
  • solubility enhancement
  • bioavailability
  • polymorphism
  • coformer selection
  • stability
  • structure prediction
  • drug formulation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop